8/30/24 16:16 | 8/28/24 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S | -1,401 | 6.32 | 0 | -222 | -3 | 6,207 | D | | | | | | | | | | | | | | |
10/19/23 15:08 | 10/17/23 | BDTX | Health | BioPrd | Biological Products, (No Diag | Biotech Growth N V | P8 | T | | P | 934 | 2.34 | 0 | 400 | 5 | 8,518 | D | | | | | | | | | | | | | | |
7/7/23 16:30 | 7/5/23 | BDTX | Health | BioPrd | Biological Products, (No Diag | Ra Capital Management, L.P. | MA | D | | P | 4,679 | 5.00 | 0 | 936 | 36 | 3,526 | I | | | | | | | | | | | | | | |
7/6/23 16:45 | 7/5/23 | BDTX | Health | BioPrd | Biological Products, (No Diag | Behbahani Ali | MD | D | | P | 5,000 | 5.00 | 0 | 1,000 | 29 | 4,490 | I | | | | | | | | | | | | | | |
7/3/23 15:36 | 6/30/23 | BDTX | Health | BioPrd | Biological Products, (No Diag | Biotech Growth N V | P8 | T | | P | 5,000 | 5.00 | 0 | 1,000 | 14 | 8,118 | D | | | | | | | | | | | | | | |
6/29/23 13:37 | 6/27/23 | BDTX | Health | BioPrd | Biological Products, (No Diag | Biotech Growth N V | P8 | T | | P | 9,555 | 5.49 | 0 | 1,740 | 32 | 7,118 | D | | | | | | | | | | | | | | |
6/28/23 16:02 | 6/27/23 | BDTX | Health | BioPrd | Biological Products, (No Diag | Epstein David M. | MA | DO | SEE REMA | S | -168 | 6.70 | 0 | -25 | -3 | 937 | D | | | | | | | | | | | | | | |
12/23/22 16:23 | 12/21/22 | BDTX | Health | BioPrd | Biological Products, (No Diag | Ni Fang | MA | O | SEE REMA | P.m | 72 | 1.28 | 0 | 56 | 82 | 125 | D | | | | | | | | | | | | | | |
11/2/22 15:10 | 10/31/22 | BDTX | Health | BioPrd | Biological Products, (No Diag | Biotech Growth N V | P8 | T | | P | 225 | 2.25 | 0 | 100 | 2 | 5,378 | D | | | | | | | | | | | | | | |
10/31/22 15:20 | 10/27/22 | BDTX | Health | BioPrd | Biological Products, (No Diag | Biotech Growth N V | P8 | T | | P.m | 736 | 2.02 | 0 | 365 | 7 | 5,278 | D | | | | | | | | | | | | | | |
10/25/22 16:24 | 10/21/22 | BDTX | Health | BioPrd | Biological Products, (No Diag | Biotech Growth N V | P8 | T | | P | 133 | 1.51 | 0 | 88 | 2 | 4,913 | D | | | | | | | | | | | | | | |
10/21/22 15:06 | 10/19/22 | BDTX | Health | BioPrd | Biological Products, (No Diag | Biotech Growth N V | P8 | T | | P.m | 179 | 1.36 | 0 | 131 | 3 | 4,826 | D | | | | | | | | | | | | | | |
6/30/22 16:05 | 6/29/22 | BDTX | Health | BioPrd | Biological Products, (No Diag | Ni Fang | MA | O | SEE REMA | P | 61 | 2.44 | 0 | 25 | 57 | 69 | D | | | | | | | | | | | | | | |
4/29/22 10:50 | 4/27/22 | BDTX | Health | BioPrd | Biological Products, (No Diag | Biotech Growth N V | P8 | T | | P.m | 1,057 | 2.61 | 0 | 406 | 9 | 4,694 | D | | | | | | | | | | | | | | |
4/20/22 12:56 | 4/18/22 | BDTX | Health | BioPrd | Biological Products, (No Diag | Biotech Growth N V | P8 | T | | P.m | 981 | 3.27 | 0 | 300 | 8 | 4,288 | D | | | | | | | | | | | | | | |
4/14/22 12:09 | 4/12/22 | BDTX | Health | BioPrd | Biological Products, (No Diag | Biotech Growth N V | P8 | T | | P.m | 880 | 3.48 | 0 | 253 | 7 | 3,988 | D | | | | | | | | | | | | | | |
5/13/21 16:53 | 5/12/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | M.d | 13 | 3.20 | 0 | 4 | 94 | 8 | D | | | | | | | | | | | | | | |
5/13/21 16:53 | 5/12/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | S.d | -112 | 27.42 | 0 | -4 | -33 | 8 | D | | | | | | | | | | | | | | |
5/5/21 16:31 | 5/3/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 27 | 10.86 | 0 | 3 | 357 | 3 | D | | | | | | | | | | | | | | |
5/5/21 16:31 | 5/3/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | S.d | -67 | 26.64 | 0 | -3 | -44 | 3 | D | | | | | | | | | | | | | | |
4/13/21 20:45 | 4/12/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | M.d | 13 | 3.20 | 0 | 4 | 94 | 8 | D | | | | | | | | | | | | | | |
4/13/21 20:45 | 4/12/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | S.d | -102 | 25.00 | 0 | -4 | -33 | 8 | D | | | | | | | | | | | | | | |
4/7/21 17:17 | 4/5/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 27 | 10.86 | 0 | 3 | 357 | 3 | D | | | | | | | | | | | | | | |
4/7/21 17:17 | 4/5/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | S.d | -64 | 25.54 | 0 | -3 | -44 | 3 | D | | | | | | | | | | | | | | |
3/16/21 16:56 | 3/12/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | M.d | 13 | 3.20 | 0 | 4 | 94 | 8 | D | | | | | | | | | | | | | | |
3/16/21 16:56 | 3/12/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | S.d | -107 | 26.36 | 0 | -4 | -33 | 8 | D | | | | | | | | | | | | | | |
3/4/21 17:52 | 3/3/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 27 | 10.86 | 0 | 3 | 357 | 3 | D | | | | | | | | | | | | | | |
3/4/21 17:52 | 3/3/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | S.d | -65 | 26.10 | 0 | -3 | -44 | 3 | D | | | | | | | | | | | | | | |
2/12/21 21:24 | 2/12/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | M.d | 13 | 3.20 | 0 | 4 | 94 | 8 | D | | | | | | | | | | | | | | |
2/12/21 21:24 | 2/12/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | S.d | -111 | 27.23 | 0 | -4 | -33 | 8 | D | | | | | | | | | | | | | | |
2/4/21 17:47 | 2/3/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 27 | 10.86 | 0 | 3 | 357 | 3 | D | | | | | | | | | | | | | | |
2/4/21 17:47 | 2/3/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | S.d | -63 | 25.35 | 0 | -3 | -44 | 3 | D | | | | | | | | | | | | | | |
1/14/21 20:57 | 1/12/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | M.d | 95 | 8.16 | 0 | 12 | | 8 | D | | | | | | | | | | | | | | |
1/14/21 20:57 | 1/12/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | S.d | -394 | 34.03 | 0 | -12 | -58 | 8 | D | | | | | | | | | | | | | | |
1/11/21 17:59 | 1/8/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Leggett Thomas | MA | O | CFO | M.d | 33 | 10.86 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
1/11/21 17:59 | 1/8/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Leggett Thomas | MA | O | CFO | S.d | -102 | 33.94 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
1/6/21 18:27 | 1/4/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 27 | 10.86 | 0 | 3 | 357 | 3 | D | | | | | | | | | | | | | | |
1/6/21 18:27 | 1/4/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | S.d | -79 | 31.41 | 0 | -3 | -44 | 3 | D | | | | | | | | | | | | | | |
1/6/21 18:21 | 1/4/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Epstein David M. | MA | DO | See Rema | M.d | 19 | 6.42 | 0 | 3 | 0 | 962 | D | | | | | | | | | | | | | | |
1/6/21 18:21 | 1/4/21 | BDTX | Health | BioPrd | Biological Products, (No Diag | Epstein David M. | MA | DO | See Rema | S.d | -374 | 31.13 | 0 | -12 | -1 | 962 | D | | | | | | | | | | | | | | |
12/29/20 16:46 | 12/28/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | M.d | 17 | 3.20 | 0 | 5 | 180 | 8 | D | | | | | | | | | | | | | | |
12/16/20 19:42 | 12/15/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 35 | 10.86 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |
12/16/20 19:41 | 12/14/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | M.d | 13 | 3.20 | 0 | 4 | | 3 | D | | | | | | | | | | | | | | |
12/16/20 19:41 | 12/14/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | S.d | -143 | 34.95 | 0 | -4 | -58 | 3 | D | | | | | | | | | | | | | | |
12/16/20 19:39 | 12/15/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Epstein David M. | MA | DO | See Rema | M.d | 16 | 6.42 | 0 | 3 | 0 | 971 | D | | | | | | | | | | | | | | |
12/10/20 16:16 | 12/8/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Leggett Thomas | MA | O | CFO | M.d | 33 | 10.86 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
12/10/20 16:16 | 12/8/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Leggett Thomas | MA | O | CFO | S.d | -101 | 33.78 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
12/4/20 16:34 | 12/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 27 | 10.86 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
12/4/20 16:34 | 12/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | S.d | -81 | 32.42 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
12/3/20 16:17 | 12/1/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Epstein David M. | MA | DO | See Rema | M.d | 19 | 6.42 | 0 | 3 | 0 | 968 | D | | | | | | | | | | | | | | |
12/3/20 16:17 | 12/1/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Epstein David M. | MA | DO | See Rema | S.d | -393 | 32.71 | 0 | -12 | -1 | 968 | D | | | | | | | | | | | | | | |
12/1/20 19:13 | 11/30/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S | -345 | 33.15 | 0 | -10 | -1 | 1,680 | M | | | | | | | | | | | | | | |
12/1/20 19:13 | 11/30/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S | -345 | 33.15 | 0 | -10 | 0 | 5,606 | M | | | | | | | | | | | | | | |
11/23/20 16:41 | 11/19/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S | -4,292 | 33.01 | 0 | -130 | -2 | 7,647 | M | | | | | | | | | | | | | | |
11/23/20 16:39 | 11/19/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S | -4,292 | 33.01 | 0 | -130 | -2 | 6,694 | I | | | | | | | | | | | | | | |
11/19/20 21:19 | 11/17/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -156 | 33.05 | 0 | -5 | 0 | 6,808 | I | | | | | | | | | | | | | | |
11/19/20 21:19 | 11/17/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -156 | 33.05 | 0 | -5 | 0 | 7,777 | M | | | | | | | | | | | | | | |
11/17/20 19:33 | 11/13/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -159 | 33.74 | 0 | -5 | 0 | 7,782 | M | | | | | | | | | | | | | | |
11/17/20 19:28 | 11/13/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -159 | 33.74 | 0 | -5 | 0 | 6,813 | I | | | | | | | | | | | | | | |
11/13/20 19:47 | 11/12/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S | -533 | 34.15 | 0 | -16 | 0 | 5,927 | M | | | | | | | | | | | | | | |
11/13/20 19:46 | 11/12/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S | -533 | 34.15 | 0 | -16 | 0 | 4,957 | M | | | | | | | | | | | | | | |
11/13/20 16:26 | 11/11/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 54 | 10.86 | 0 | 5 | | 0 | D | | | | | | | | | | | | | | |
11/13/20 16:26 | 11/11/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | S.d | -175 | 34.90 | 0 | -5 | -100 | 0 | D | | | | | | | | | | | | | | |
11/13/20 16:25 | 11/12/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | M.d | 13 | 3.20 | 0 | 4 | | 3 | D | | | | | | | | | | | | | | |
11/13/20 16:25 | 11/12/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | S.d | -139 | 33.99 | 0 | -4 | -58 | 3 | D | | | | | | | | | | | | | | |
11/12/20 17:41 | 11/10/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -1,350 | 34.11 | 0 | -40 | 0 | 8,752 | M | | | | | | | | | | | | | | |
11/12/20 17:38 | 11/10/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -1,350 | 34.11 | 0 | -40 | -1 | 7,775 | I | | | | | | | | | | | | | | |
11/12/20 17:00 | 11/9/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Leggett Thomas | MA | O | CFO | M.d | 33 | 10.86 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
11/12/20 17:00 | 11/9/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Leggett Thomas | MA | O | CFO | S.d | -99 | 32.96 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
11/10/20 19:24 | 11/6/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -311 | 33.08 | 0 | -9 | 0 | 8,791 | M | | | | | | | | | | | | | | |
11/10/20 19:24 | 11/6/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -311 | 33.08 | 0 | -9 | 0 | 7,810 | I | | | | | | | | | | | | | | |
11/6/20 16:49 | 11/4/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -376 | 33.14 | 0 | -11 | 0 | 7,818 | I | | | | | | | | | | | | | | |
11/6/20 16:44 | 11/4/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -376 | 33.14 | 0 | -11 | 0 | 8,801 | M | | | | | | | | | | | | | | |
11/4/20 20:37 | 11/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 27 | 10.86 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
11/4/20 20:37 | 11/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | S.d | -80 | 31.95 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
11/3/20 19:56 | 11/2/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Epstein David M. | MA | DO | See Rema | M.d | 19 | 6.42 | 0 | 3 | 0 | 977 | D | | | | | | | | | | | | | | |
11/3/20 19:56 | 11/2/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Epstein David M. | MA | DO | See Rema | S.d | -374 | 31.14 | 0 | -12 | -1 | 977 | D | | | | | | | | | | | | | | |
10/28/20 17:58 | 10/26/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -296 | 33.28 | 0 | -9 | 0 | 8,812 | M | | | | | | | | | | | | | | |
10/28/20 17:51 | 10/26/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -296 | 33.28 | 0 | -9 | 0 | 7,828 | I | | | | | | | | | | | | | | |
10/20/20 20:09 | 10/15/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -527 | 33.44 | 0 | -16 | 0 | 8,821 | M | | | | | | | | | | | | | | |
10/20/20 20:03 | 10/15/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -527 | 33.44 | 0 | -16 | 0 | 7,836 | I | | | | | | | | | | | | | | |
10/15/20 19:26 | 10/13/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -574 | 33.30 | 0 | -17 | 0 | 7,850 | I | | | | | | | | | | | | | | |
10/15/20 19:22 | 10/13/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -574 | 33.30 | 0 | -17 | 0 | 8,837 | M | | | | | | | | | | | | | | |
10/14/20 16:32 | 10/12/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | M.d | 13 | 3.20 | 0 | 4 | | 3 | D | | | | | | | | | | | | | | |
10/14/20 16:32 | 10/12/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | S.d | -133 | 32.70 | 0 | -4 | -58 | 3 | D | | | | | | | | | | | | | | |
10/13/20 19:48 | 10/8/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -758 | 33.50 | 0 | -23 | 0 | 7,865 | I | | | | | | | | | | | | | | |
10/13/20 19:41 | 10/8/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -758 | 33.50 | 0 | -23 | 0 | 8,854 | M | | | | | | | | | | | | | | |
10/9/20 16:12 | 10/8/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Leggett Thomas | MA | O | CFO | M.d | 33 | 10.86 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
10/9/20 16:12 | 10/8/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Leggett Thomas | MA | O | CFO | S.d | -101 | 33.53 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
10/8/20 19:14 | 10/6/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -1,536 | 33.44 | 0 | -46 | -82 | 10 | M | | | | | | | | | | | | | | |
10/8/20 19:14 | 10/6/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -1,536 | 33.44 | 0 | -46 | -1 | 5,757 | M | | | | | | | | | | | | | | |
10/7/20 16:27 | 10/5/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 27 | 10.86 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
10/7/20 16:27 | 10/5/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | S.d | -78 | 31.28 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
10/2/20 17:07 | 10/1/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Epstein David M. | MA | DO | See Rema | M.d | 19 | 6.42 | 0 | 3 | 0 | 986 | D | | | | | | | | | | | | | | |
10/2/20 17:07 | 10/1/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Epstein David M. | MA | DO | See Rema | S.d | -364 | 30.33 | 0 | -12 | -1 | 986 | D | | | | | | | | | | | | | | |
10/1/20 16:06 | 9/30/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Ingram Robert Alexander | MA | D | | P | 152 | 30.46 | 0 | 5 | New | 5 | D | | | | | | | | | | | | | | |
9/16/20 18:11 | 9/14/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | M.d | 13 | 3.20 | 0 | 4 | | 3 | D | | | | | | | | | | | | | | |
9/16/20 18:11 | 9/14/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | S.d | -127 | 31.04 | 0 | -4 | -58 | 3 | D | | | | | | | | | | | | | | |
9/16/20 18:09 | 9/14/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Leggett Thomas | MA | O | CFO | M.d | 33 | 10.86 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
9/16/20 18:09 | 9/14/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Leggett Thomas | MA | O | CFO | S.d | -93 | 31.00 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
9/4/20 17:27 | 9/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | M.d | 27 | 10.86 | 0 | 3 | | 0 | D | | | | | | | | | | | | | | |
9/4/20 17:27 | 9/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Roberts Christopher D. | MA | O | Chief Sc | S.d | -74 | 29.60 | 0 | -3 | -100 | 0 | D | | | | | | | | | | | | | | |
8/12/20 19:57 | 8/10/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | S.m | -456 | 33.06 | 0 | -14 | 0 | 10,541 | M | | | | | | | | | | | | | | |
8/12/20 19:46 | 8/10/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | DT | | S.m | -456 | 33.06 | 0 | -14 | 0 | 9,417 | I | | | | | | | | | | | | | | |
2/5/20 18:02 | 2/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | | P.d | 17,000 | 19.00 | 0 | 895 | 13 | 8,016 | M | | | | | | | | | | | | | | |
2/5/20 17:59 | 2/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Bolzon Bradley J Phd | MA | D | | P.d | 17,000 | 19.00 | 0 | 895 | 287 | 1,207 | I | | | | | | | | | | | | | | |
2/5/20 17:58 | 2/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Shah Rajeev M. | MA | D | | P.d | 19,000 | 19.00 | 0 | 1,000 | | 354 | I | | | | | | | | | | | | | | |
2/5/20 17:55 | 2/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Hatzis-Schoch Brent | MA | O | See Rema | P | 57 | 19.00 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |
2/5/20 17:55 | 2/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Behbahani Ali | MD | D | | P.d | 15,200 | 19.00 | 0 | 800 | 30 | 3,449 | I | | | | | | | | | | | | | | |
2/3/20 13:25 | 2/3/20 | BDTX | Health | BioPrd | Biological Products, (No Diag | Flynn James E | NY | TH | Possible | P.d | 7,600 | 19.00 | 0 | 400 | 106 | 779 | I | | | | | | | | | | | | | | |